ArticleIn vivo (Athens, Greece)

Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer.

Yuko Kumagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.